Y-Intercept (HK)’s Medifast MED Stock Holding History

Y-Intercept (HK)’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,188	Closed	-$886K	–	1608
2023 Q4	$886K	Buy	+13,188	New	+$919K	0.08%	358
2023 Q1	–	Sell	-4,060	Closed	-$468K	–	1394
2022 Q4	$468K	Buy	4,060 +191	+5%	+$22.2K	0.07%	459
2022 Q3	$419K	Buy	+3,869	New	+$554K	0.04%	600
2021 Q4	–	Sell	-2,013	Closed	-$388K	–	760
2021 Q3	$388K	Buy	2,013 +1,067	+113%	+$262K	0.07%	404
2021 Q2	$268K	Buy	+946	New	+$256K	0.07%	444

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Y-Intercept (HK)'s MED Position: Q1 2024 in Review

Y-Intercept (HK) sold out of Medifast (MED) in Q1 2024, closing a stake of 13,188 shares — an estimated $886K sold.

Y-Intercept (HK) first reported a position in MED in Q2 2021 and held it in 5 quarters. The position peaked at $886K in Q4 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

Y-Intercept (HK) reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
Y-Intercept (HK) sold 13,188 Medifast shares in Q1 2024, an estimated $886K.
Y-Intercept (HK) first reported a position in Medifast in Q2 2021 and held it in 5 quarters.
Y-Intercept (HK)'s Medifast position peaked at $886K in Q4 2023.
186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Y-Intercept (HK)'s 13F filing for Q1 2024, filed 10 May 2024.